Targeted Cardiovascular Protection with INCLOP
– Clinically formulated Atorvastatin & Clopidogrel Capsules
Dual-Action Cardiovascular Defense:
INCLOP combines two potent medications to simultaneously manage cholesterol levels and prevent harmful blood clots, significantly reducing the risk of major cardiovascular events.
Superior Lipid Management:
The inclusion of Atorvastatin effectively lowers "bad" cholesterol (LDL) and triglycerides while raising "good" cholesterol (HDL), stabilizing arterial plaques for long-term heart health.
Effective Antiplatelet Protection:
Clopidogrel acts as a powerful blood thinner, keeping platelets from clumping together to ensure smooth blood flow and protect against heart attacks and strokes.
INCLOP | Atorvastatin & Clopidogrel Capsules
Authoritative product information and registered documentation from FENESTRA PHARMACEUTICALS.
INCLOP Official Product, INCLOP Product Details.
Comprehensive INCLOP Overview
INCLOP is a specialized prescription cardiovascular medication marketed by Fenestra Pharmaceuticals. It is a powerful, dual-action formula that combines a lipid-lowering agent (Atorvastatin) with an antiplatelet medication (Clopidogrel). This combination is clinically indicated for reducing the risk of major cardiovascular events, managing high cholesterol, and preventing the formation of harmful blood clots in patients with a high risk of heart attack or stroke.
Key Composition and Features
- Active Ingredients: Atorvastatin & Clopidogrel.
- Dual Mechanism: Atorvastatin helps lower “bad” cholesterol (LDL) and stabilizes arterial plaques, while Clopidogrel keeps blood flowing smoothly by preventing platelets from sticking together and forming clots.
- Packaging: Available in a standard 10 x 10 Capsules strip format.
Usage and Dosage Guidelines
INCLOP is a Prescription Drug (Rx).
- Dosage: Strictly to be taken as directed by the Physician. It is typically taken once daily, with or without food.
- Retail Restriction: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
Registered Documentation and Manufacturing
INCLOP is produced under strict quality control standards, ensuring cardiovascular safety and compliance:
- Marketing Entity: Marketed by Fenestra Pharmaceuticals Pvt Ltd, an ISO 9001:2015 Certified Company based at No. 751, 8th Cross, 4th Main M.C. Layout, Vijaynagar, Bangalore – 560040.
- Manufacturing License: Mfg. Lic. No.: 31/UA/2013.
Would you like the website banner text next, or should we move to the doctor testimonials?
testimonials
Product Feedback & Reviews
Share your experience with Fenestra’s products—your feedback helps us enhance quality and ensure customer satisfaction
"For my high-risk cardiovascular patients, I prescribe INCLOP for its dependable dual-action formulation. By combining Atorvastatin and Clopidogrel, it effectively manages lipid profiles while offering crucial antiplatelet protection to prevent future cardiac events."
Dr. Rajesh Khanna, General Physician 
"Managing post-stent and acute coronary syndrome patients requires reliable medications. INCLOP offers an excellent synergistic approach, ensuring my patients get standard-of-care protection against plaque buildup and arterial clotting."
Dr. Priya SharmaConsulting Physician 
"INCLOP is an essential part of my clinical approach for patients requiring aggressive cardiovascular risk reduction. The quality standards from Fenestra Pharmaceuticals give me confidence in its long-term safety and efficacy."
Dr. Ananya DesaiFamily Medicine Specialist 